Evaluation of liver parenchyma with shear wave elastography in patients with rheumatoid arthritis receiving disease‐modifying antirheumatic drug therapy
Journal of Clinical Ultrasound · 2025
DOI: 10.1002/jcu.23847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Ultrasound, 2025. Verfasst von Dilek Tezcan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Rheumatology, Gülhane Faculty of Medicine, University of Health Sciences Turkey, Ankara, Turkey. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Arthritis, Rheumatoid, Antirheumatic Agents, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Methotrexate (MTX) and leflunomide (LEF) play fundamental roles in rheumatoid arthritis (RA) treatment and require proper monitoring of side effects. Concerns about MTX/LEF‐related liver fibrosis (LF) in patients with RA remain unclear. This study investigated liver stiffness using two‐dimensional shear wave elastography (2D‐SWE) in RA patients undergoing disease‐modifying antirheumatic drug (DMARD) therapy. Moreover, 2D‐SWE was employed to evaluate the correlations between liver stiffness, cumulative MTX and LEF doses and risk factors for substantial LF.
Methods
We recruited 222 participants from the Department of Rheumatology. The participants were divided into healthy controls ( n = 78) and patients with RA ( n = 144). Pearson's correlation analysis was performed to assess the correlations between liver stiffness and the cumulative dose of MTX/LEF and other clinical and laboratory variables.
Results
The mean elasticity modulus was 4.79 ± 0.92 kPa, excluding the presence of significant fibrosis. Mean 2D‐SWE values were significantly lower in healthy controls than in RA treated with MTX and LEF. The cut‐off ≥3.8 kPa 2D‐SWE values with the sensitivity of 86.1%, specifity of 83.3%. 2D‐SWE values were not significantly different across the strata of the cumulative MTX subgroups.
Conclusions
MTX and LEF increase liver stiffness but may be considered low risk for the development of LF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Rheumatology, Gülhane Faculty of Medicine, University of Health Sciences Turkey, Ankara, Turkey.
- Division of Radiology, Selcuk University Faculty of Medicine, Konya, Turkey.
- Division of Rheumatology, Selcuk University Faculty of Medicine, Konya, Turkey.
ORCID-Profile: Dilek Tezcan, Halil Özer, Ömer Faruk Topaloğlu, Selda Hakbilen, Mehmet Sedat Durmaz, Sema Yılmaz, Mehmet Öztürk
Zitieren
APA
Tezcan, D., Özer, H., Topaloğlu, Ö. F., Hakbilen, S., Durmaz, M. S., Yılmaz, S., & Öztürk, M. (2025). Evaluation of liver parenchyma with shear wave elastography in patients with rheumatoid arthritis receiving disease‐modifying antirheumatic drug therapy. Journal of Clinical Ultrasound. https://doi.org/10.1002/jcu.23847
Vancouver
Tezcan D, Özer H, Topaloğlu ÖF, Hakbilen S, Durmaz MS, Yılmaz S, et al. Evaluation of liver parenchyma with shear wave elastography in patients with rheumatoid arthritis receiving disease‐modifying antirheumatic drug therapy. Journal of Clinical Ultrasound. 2025. doi:10.1002/jcu.23847
BibTeX
@article{Tezcan2025,
author = {Tezcan, Dilek and Özer, Halil and Topaloğlu, Ömer Faruk and Hakbilen, Selda and Durmaz, Mehmet Sedat and Yılmaz, Sema and Öztürk, Mehmet},
title = {Evaluation of liver parenchyma with shear wave elastography in patients with rheumatoid arthritis receiving disease‐modifying antirheumatic drug therapy},
journal = {Journal of Clinical Ultrasound},
year = {2025},
doi = {10.1002/jcu.23847}
}
EUVIMED